Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120)

Steven M. Sparks(GlaxoSmithKline (United States)), Grace Chen(GlaxoSmithKline (United States)), Jon L. Collins(Research Triangle Park Foundation), Dana P. Danger(Research Triangle Park Foundation), Steven T. Dock(GlaxoSmithKline (United States)), Channa Jayawickreme(Research Triangle Park Foundation), Stephen Jenkinson(Research Triangle Park Foundation), Christopher P. Laudeman(Research Triangle Park Foundation), M. Anthony Leesnitzer(Research Triangle Park Foundation), Xi Liang(GlaxoSmithKline (United States)), Patrick Maloney(Research Triangle Park Foundation), David C. McCoy(Research Triangle Park Foundation), David Moncol(GlaxoSmithKline (United States)), Vincent Rash(GlaxoSmithKline (United States)), Thomas J. Rimele(Research Triangle Park Foundation), Padmaja Vulimiri(GlaxoSmithKline (United States)), James M. Way(Research Triangle Park Foundation), Sean Ross(Research Triangle Park Foundation)
Bioorganic & Medicinal Chemistry Letters
May 15, 2014
10.1016/j.bmcl.2014.05.012
Cited by 104Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis